Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IsoCOMFORT: Isoflurane vs Midazolam for Sedation in Pediatric ICU
NCT04684238Phase 3Completed
- Sponsor
- Sedana Medical
- Start
- Jan 2021
- Primary completion
- Jan 2023
- Modality
- Allosteric Modulators
- Countries
- 5
01
Overview
Phase 3, randomised, single-blind trial of isoflurane in sedation (2 arms), sponsored by Sedana Medical. Primary endpoint: Percentage of Time of Adequately Maintained Sedation Depth. Started Jan 2021; status: completed.
02
Drugs
isoflurane
03
Conditions
sedation
Beyond the preview
Go deeper on NCT04684238.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04684238.